NovoCure Ltd — Director's Dealing 2015

Oct 1, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2015-10-01

Reporting Person: GROENHUYSEN WILHELMUS CM (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	263128	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to Buy Ordinary Shares	$3.44	2021-12-14	Ordinary Shares (523732)		Direct
Options to Buy Ordinary Shares	$7.03	2023-02-20	Ordinary Shares (88695)		Direct
Options to Buy Ordinary Shares	$7.48	2024-02-26	Ordinary Shares (59130)		Direct
Options to Buy Ordinary Shares	$14.37	2025-02-25	Ordinary Shares (266085)		Direct

Footnotes

F1: Options to buy 327,017 ordinary shares are vested and currently exercisable as of the date hereof. The remaining options to buy 196,715 ordinary shares will vest and become exercisable on January 1, 2016, subject to Mr. Groenhuysen's continued employment through such date.

F2: Options to buy 44,347 ordinary shares are vested and currently exercisable as of the date hereof. The remaining options to buy 44,348 ordinary shares will vest and become exercisable in equal installments on February 20, 2016 and 2017, subject to Mr. Groenhuysen's continued employment through such dates.

F3: Options to buy 14,782 ordinary shares are vested and currently exercisable as of the date hereof. The remaining options to buy 44,348 ordinary shares will vest and become exercisable in equal installments on each of February 26, 2016, 2017 and 2018, subject to Mr. Groenhuysen's continued employment through such dates.

F4: The options to buy 266,085 ordinary shares will vest and become exercisable in equal installments on each of the first four anniversaries of February 25, 2015, subject to Mr. Groenhuysen's continued employment through such dates.